Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia [Phase 3]
A pilot, randomized, double-blind study comparing oseltamivir to placebo for immune thrombocytopenia in a Phase 3 setting; status currently …
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia
A clinical trial update investigating eltrombopag in combination with recombinant human thrombopoietin for corticosteroid-resistant or relap…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia [Phase 2]
Phase 2 trial evaluating romiplostim, rituximab, and dexamethasone as frontline treatment for immune thrombocytopenia and thrombotic thrombo…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Combination of Danazole With Berberine in the Treatment of ITP [Phase 2]
A Phase 2 trial evaluating the combination of Danazol with Berberine for corticosteroid-resistant or relapsed immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS withdrawal · 2020-09-14Clinical Trial Update: A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP) [Phase 3]
Phase 3 clinical trial evaluating efgartigimod for adult primary immune thrombocytopenia has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP [Phase 4]
Phase 4 randomized study comparing vitamin D added to high-dose dexamethasone versus high-dose dexamethasone alone for immune thrombocytopen…
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) [Phase 2]
Phase 2 trial comparing eltrombopag plus rhTPO to eltrombopag alone for immune thrombocytopenia during COVID-19.
-
FDA approval · 2020-08-20FDA Approved: DOPTELET — Supplemental Application (AkaRx, Inc.)
FDA approved a supplemental application for DOPTELET (avatrombopag maleate) from AkaRx, Inc., likely expanding labeling or indications.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults [Phase 4]
A Phase 4 clinical trial comparing eltrombopag alone versus eltrombopag combined with rituximab in adults with primary immune thrombocytopen…
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 trial exploring the combination of terbutaline and danazol for steroid-resistant/relapse immune thrombocytopenia. Status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Immunomodulation With Romiplostim in Young Adults With ITP [Phase 4]
Phase 4 trial update on immunomodulation with romiplostim in young adults with immune thrombocytopenia has been completed.
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP [Phase 2]
Phase 2 trial evaluating high-dose dexamethasone plus acetylcysteine for newly diagnosed immune thrombocytopenia is in early stages with sta…
-
FDA approval · 2020-04-29FDA Approved: PROMACTA — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for PROMACTA (eltrombopag olamine) by Novartis Pharmaceuticals Corporation. This action updates the …
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy [Phase 3]
Phase 3 multicenter trial evaluating recombinant human thrombopoietin for managing immune thrombocytopenia in pregnancy has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Caffeic Acid Combining High-dose Dexamethasone in Management of ITP [Phase 4]
Phase 4 clinical trial update on using caffeic acid in combination with high-dose dexamethasone for immune thrombocytopenia (ITP) completed.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia [Phase 2]
Phase II trial investigating romiplostim with danazol for patients with eltrombopag-resistant immune thrombocytopenia is ongoing (Phase II, …
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Open Label Extension Study of AMG 531 in Japanese Subjects With ITP [Phase 2, Phase 3]
Open-label extension study of AMG 531 in Japanese subjects with immune thrombocytopenic purpura (ITP) completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura [Phase 4]
A Phase 4 clinical trial evaluating whether eradication of Helicobacter pylori affects outcomes in children with chronic immune thrombocytop…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of rhTPO and eltrombopag in patients with primary immune thrombocytopenia.
-
FDA approval · 2019-10-17FDA Approved: NPLATE — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for NPLATE (romiplostim) from Amgen.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Eltrombopag in Chronic ITP [Phase 4]
Phase 4 clinical trial update for eltrombopag in chronic immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 clinical trial evaluating different rhTPO regimens for efficacy and safety in patients with primary immune thrombocytopenia (ITP) ha…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) [Phase 3]
Long-term phase 3 trial in pediatric patients with immune thrombocytopenia assessing romiplostim safety and efficacy; study completed with r…
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP) [Phase 3]
A Phase 3 clinical trial update for BT595 in chronic primary immune thrombocytopenia (ITP) has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Safety and Efficacy of Eltrombopag at Escalated Doses [Phase 2]
Phase 2 trial assessing safety and efficacy of escalated doses of eltrombopag in immune thrombocytopenia, with completed status and results …